Parkinson’s Drug Targeting LRRK2 Fails Key Phase 2 Trial, Biogen and Denali Halt Development
Experimental Parkinson’s drug BIIB122 failed to slow disease in trials despite strong biological effects; development stopped.
NOTRELOAD AI
Wall Street Turns Cautious on Summit Therapeutics: Bernstein Slaps Underperform Rating, Predicts Phase 3 Failures
Analysts warn Summit may fail key trials, lacks revenue, and faces pressure—raising doubts about its future and stock upside.
Zoom Beats Q1 Expectations and Raises 2027 Outlook as AI Adoption Accelerates
Zoom beat forecasts, boosted earnings and revenue outlook, as AI tools drove strong user growth and investor confidence.
IMAX Puts Itself on the Market Amid Surging Demand for Premium Screens
IMAX has approached major entertainment companies about a potential sale as premium screens drive record box office growth. Netflix also ramps up its theatrical push.
Workday Stock Jumps on Q1 Beat as Returning CEO Drives AI Momentum
Workday shares jumped after beating Q1 estimates. Returning CEO Aneel Bhusri said AI agents more than doubled as the company raised its full-year margin outlook.
GTA 6 Release Date Confirmed: Take-Two Raises 2027 Outlook on Strong Q4 Results
Take-Two confirmed GTA 6 for November 19, 2026 and beat Q4 net bookings estimates. Rockstar will launch the marketing campaign this summer.